While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Cash flow is valuable, but it’s not everything - StockStory helps you identify the companies that truly put it to work. Keeping that in mind, here are three cash-producing companies to steer clear of and a few better alternatives.
Everforth (EFOR)
Trailing 12-Month Free Cash Flow Margin: 5.6%
Evolving from its roots in IT staffing to become a high-end technology consulting powerhouse, Everforth (EFOR) provides specialized IT consulting services and staffing solutions to Fortune 1000 companies and U.S. federal government agencies.
Why Are We Bearish on EFOR?
- Customers postponed purchases of its products and services this cycle as its revenue declined by 3.7% annually over the last two years
- Estimated sales growth of 1% for the next 12 months is soft and implies weaker demand
- Earnings per share have dipped by 4.3% annually over the past five years, which is concerning because stock prices follow EPS over the long term
At $37.77 per share, Everforth trades at 9.1x forward P/E. Check out our free in-depth research report to learn more about why EFOR doesn’t pass our bar.
Amdocs (DOX)
Trailing 12-Month Free Cash Flow Margin: 13.7%
Powering the digital experiences of approximately 400 communications companies worldwide, Amdocs (NASDAQ:DOX) provides software and services that help telecommunications and media companies manage customer relationships, monetize services, and automate network operations.
Why Are We Out on DOX?
- Products and services are facing significant end-market challenges during this cycle as sales have declined by 3.4% annually over the last two years
- Demand will likely be soft over the next 12 months as Wall Street’s estimates imply tepid growth of 3.4%
- Diminishing returns on capital suggest its earlier profit pools are drying up
Amdocs’s stock price of $58.62 implies a valuation ratio of 7.7x forward P/E. Dive into our free research report to see why there are better opportunities than DOX.
Diebold Nixdorf (DBD)
Trailing 12-Month Free Cash Flow Margin: 5.5%
With roots dating back to 1859 and a presence in over 100 countries, Diebold Nixdorf (NYSE:DBD) provides automated self-service technology, software, and services that help banks and retailers digitize their customer transactions.
Why Should You Sell DBD?
- Products and services are facing end-market challenges during this cycle, as seen in its flat sales over the last five years
- Earnings per share have contracted by 8.4% annually over the last two years, a headwind for returns as stock prices often echo long-term EPS performance
- Low free cash flow margin of -0.7% for the last five years gives it little breathing room, constraining its ability to self-fund growth or return capital to shareholders
Diebold Nixdorf is trading at $63.04 per share, or 9.9x forward P/E. To fully understand why you should be careful with DBD, check out our full research report (it’s free).
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.